Cargando…
Lipid moieties of Mycoplasma pneumoniae lipoproteins are the causative factor of vaccine-enhanced disease
Vaccine-enhanced disease (VED) occurs as a result of vaccination followed by infection with virulent Mycoplasma pneumoniae. To date VED has prevented development of an efficacious vaccine against this significant human respiratory pathogen. Herein we report that vaccination of BALB/c mice with M. pn...
Autores principales: | Mara, Arlind B., Gavitt, Tyler D., Tulman, Edan R., Geary, Steven J., Szczepanek, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142147/ https://www.ncbi.nlm.nih.gov/pubmed/32284882 http://dx.doi.org/10.1038/s41541-020-0181-x |
Ejemplares similares
-
Vaccination with Mycoplasma pneumoniae membrane lipoproteins induces IL-17A driven neutrophilia that mediates Vaccine-Enhanced Disease
por: Mara, Arlind B., et al.
Publicado: (2022) -
B cells oppose Mycoplasma
pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs
por: Gavitt, Tyler D., et al.
Publicado: (2022) -
Semi-automated Curation of Metabolic Models via Flux Balance Analysis: A Case Study with Mycoplasma gallisepticum
por: Bautista, Eddy J., et al.
Publicado: (2013) -
Location of attachment moiety on Mycoplasma pneumoniae.
por: Collier, A. M., et al.
Publicado: (1983) -
Mycoplasma pneumonia and stroke: causation, association, or
coincidence?
por: Abdulsalam, Ahmad J., et al.
Publicado: (2021)